Latest News
Recent milestones and laboratory updates.
June 2026
New preclinical data demonstrates tumour growth stop in GBM models
Results published in a leading radiation oncology journal show significant improvement in survival when RadioPDT nanoparticles are combined with standard fractionated radiotherapy. Stops tumour growth where radiation alone cannot.
March 2026
Presented at ASTRO Annual Meeting — invited oral session
Dr. Deepak Dinakaran presented the latest translational data to a standing-room-only audience at the premier radiation oncology conference.
January 2026
Expanded IP portfolio with new composition-of-matter claims
Additional patent filings strengthen the company's position in radiation-activated nanoparticle therapeutics for solid tumors. Now 4 patent families with 2018 priority date.